Skip to main content
. 2024 Oct 17;15(5):101070. doi: 10.1016/j.jaim.2024.101070

Table 4.

Distribution of malignant brain tumour patients and effect of Raupya Suvarna Sutshekhara (RSS) on clinical symptoms of malignant brain tumour patients.

Symptoms No. of patients (%) Mean ± SE
p-value
Before After
1. Confusion/Disorientation 4 (3.6) 2.25 ±0.22 1.25 0.16 NS
2. Constipation 12 (10.9) 1.92 ± 0.29 0.83 ± 0.21 0.005
3. Difficulty Thinking, speaking or Articulating 29 (26.4) 1.72 ± 1.10 0.20 ± 0.13 0.01
4. Facial Numbness or Tingling 5 (4.5) 1.40± 0.40 1.20 ± 0.20 NS
5. Generalized weakness/Muscle weakness 49 (44.5) 1.86 ± 0.11 1.43 ± 0.12 0.004
6. Headaches 34 (30.9) 1.71 ± 0.16 1 ± 0.12 0.0007
7. Lack of Concentration 7 (6.4) 0.57 ± 0.09 1.29 ± 0.15 NS
8. Lethargy 5 (4.5) 1.40 ± 0.14 1.60 ± 0.14 NS
9. Loss of Appetite 25 (22.7) 1.80 ± 0.15 1.16 ± 0.17 0.004
10. Loss of Balance/dizziness 44 (40) 1.81 ± 0.14 1.22 ± 0.15 0.006
11. Memory Loss 25 (22.7) 1.80 ± 0.19 1.20 ± 0.14 0.005
12. Nausea or vomiting 16 (14.5) 1.44 ± 0.24 0.44 ± 0.16 0.008
13. Seizures/Convulsions 8 (7.3) 1.38 ± 0.32 0.5 ± 0.19 0.05
14. Sleep Disturbances 4 (3.6) 1.5 ± 0.15 1 ± 0.12 NS
15. Stool Incontinence 2 (1.8) 2.5 ± 0.24 0.5 ± 0.07 NS
16. Swallowing difficulties 2 (1.8) 0.67 ± 0.67 1.67 ± 0.33 NS
17. Tremors/Tingling sensation in Extremities 14 (12.7) 1 ± 0.21 0.36 ± 0.37 NS
18. Urine Incontinence 9 (8.2) 0.15 ± 0.05 0.07 ± 0.04 0.02
19. Vision changes 15 (13.6) 1.67 ± 0.25 1.60 ± 0.19 NS
20. Weakness/Paralysis in one part or one side of the body 44 (40) 1.93± 0.14 0.39 ± 0.12 0.04

Data presented in Mean ± SE, the difference in the mean of symptoms gradations were compared by using paired ‘t’ test.